Glimepiride (0.5 mg/day) administration improves glycemic control without weight gain in Japanese type 2 diabetic patients

Journal of the Japan Diabetes Society

Volumn 50, Issue 12, 2007, Pages 835-841

  Urakaze, Masaharu ^a   Yamazaki, Katsuya ^a   Usui, Isao ^a   Iwata, Minoru ^a   Uno, Tatsuhito ^a   Murakami, Shihou ^b   Yamamoto, Yuki ^c   Kishida, Mika ^d   Aikawa, Hidehiko ^e   Kawahara, Junko ^f   Senda, Satoko ^f   Ishizuka, Ken ^f   Ikemoto, Masahito ^g   Sawazaki, Shigeki ^h   Fukui, Kazuhito ⁱ   Takano, Atsuko ^j   Yamazaki, Yu ^j   Hori, Hiroyuki ^j   Wada, Osamu ^k   Kamura, Yutaka ^l   Igarashi, Yasuhito ^l   Sato, Akira ^l   Fukushima, Yasuo ^m   Takata, Michiyo ⁿ   Temaru, Rie ^m   Ohgaku, Seiji ^o   Akagawa, Naoji ^c   Kato, Hiromi ⁿ   Kobayashi, Masashi ^a   more..

^a TOYAMA UNIVERSITY HOSPITAL   (Japan)

^b Itoigawa General Hospital

^c ASAHI GENERAL HOSPITAL   (Japan)

^d Saiseikai Toyama Hospital   (Japan)

^e Koshi Rehabilitation Hospital

^f TOYAMA RED CROSS HOSPITAL   (Japan)

^g Nunose Medical Clinic

^h Hida City Hospital

ⁱ Takaoka City Hospital

^j Saiseikai Takaoka Hospital   (Japan)

^k Shakaihoken Takaoka Hospital   (Japan)

^l Hakuikan Hospital

^m Nanto Municipal Hospital

ⁿ Himi Municipal Hospital

^o Ohgaku Clinic

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38749107835     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A, Yamauchi M, Takagi H, Kawai K ; Japan Diatetes Clinical Data Management Study Group (2006) The status of diabetes control and antidiabetic drug therapy in Japan - a cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1) Diabetes Res Clin Pract 73 : 198-204
2. Diabetes Frontier 17 : 379-383
3. Japanese source
4. Muller G, Satoh Y, Geisen K (1995) Extrapancreatic effects of sulfonylureas - a comparison between glimepiride and conventional sulfonylureas. Diabetes Res Clin Pract 28(Suppl): S115-S137
5. Takada Y, Takata Y, Iwanishi M, Imamura T, Sawa T, Morioka H, Ishihara H, Ishiki M, Usui I, Temaru R, Urakaze M, Satoh Y, Inami T, Tsuda S, Kobayashi M (1996) Effect of glimepiride (HOE 490) on insulin receptors of skeletal muscles from genetically diabetic KK-Ay mouse. Eur J Pharmacol 308 : 205-210
6. Draeger KE, Wernicke-Panten K, Lomp HJ, Schuler E, Rosskamp R (1996) Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide. Horm Metab Res 28 : 419-425
7. Dills DG, Schneider J (1996) Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group. Horm Metab Res 28 : 426-429
8. Japanese source
9. Scholz GH, Schneider K, Knirsch W, Becker G (2001) Efficacy and tolerability of glimepiride in daily practice : A non-interventional observational cohort study. Clin Drug Invest 21 : 597-604
10. Japanese source
11. Weitgasser R, Lechleitner M, Luger A, Klingler A (2003) Effects of glimepiride on HbA1C and body weight in Type 2 diabetes : results of a 1.5-year follow-up study. Diabetes Res Clin Pract 61 : 13-19
12. Chaudhry ZW, Gannon MC, Nuttall FQ (2006) Stability of Body Weight in Type 2 Diabetes. Diabetes Care 29 : 493-497
13. Del Guerra S, Marselli L, Lupi R, Boggi U, Mosca F, Benzi L, Del Prato S, Marchetti P (2005) Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets. J Diabetes Complications 19 : 60-64
14. Campbell RK (1998) Glimepiride : role of a new sulfonylurea in the treatment of type 2 diabetes mellitus. Ann Pharmacotherapy 32 : 1044-1052
15. Japanese source
16. Japanese source
17. Japanese source